The Global Market for Research ELISA (Enzyme-Linked Immunosorbent Assay) is Projected to Reach US$177.7 Million by 2024

Continuing Use of ELISA as a Validation Technique Drives the Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market size, share and demand forecasts on the global Research ELISA (Enzyme-Linked Immunosorbent Assay) market. The global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) is projected to reach US$177.7 million by 2024, driven by the use of ELISA in validation of results post multiplexing in select targets and development of new products for niche applications.

Enzyme-Linked Immunosorbent Assay (ELISA) is one of the few assay formats that has managed to command widespread popularity, in terms of reproducibility, performance and validation in a rapidly changing life sciences and drug discovery market. Over four decades into existence, the single-analyte quantitation ELISA technique has matured and has been yielding to pressure from emergence and growing adoption of multiplex proteomic array platforms that simultaneously analyze multiple analytes and improve throughput. Factors such as high degree of intra and inter-assay reproducibility as well as reliability and affordability, however, have kept researchers interest in ELISA products, particularly in secondary validation following multiplexing. Low cost is the key advantage that ELISA holds over competing techniques, which is driving its demand. Quality and established credential of Research ELISA products are other drivers of growth.

The cost-effective Research ELISA products are preferred by certain laboratories and researchers focused on less number of analytes and high sensitivity of ELISA assays. Besides, emergence of new products and those targeting niche markets with low or no presence of multiplexing in addition to product improvements are buoying market growth. Manufacturers’ focus on niche markets and on development of innovative products in a bid to counteract challenges from competing techniques is key to fueling growth in the market. Advancements in the form of indirect ELISA and sandwich ELISA formats that have enhanced capabilities of ELISA have been instrumental in the renaissance of the technique. Advancements at the level of detection chemistries from colorimetric readouts to various fluorescent as well as chemiluminescence readouts have ensured ELISA remained relevant in research market. Continuing investments in to the ELISA space is likely to further enhance innovation in the space, spurring demand growth through the analysis period.

 

As stated by the new market research report on Research ELISA (Enzyme-Linked Immunosorbent Assay), the U.S. represents the largest market worldwide. A strong domestic pharmaceutical and biotechnology industry, presence of major drug innovators and research institutions, and continuing investments in lifescience and pharmaceutical research among other factors lead to higher demand for ELISA products in the country. Asia-Pacific ranks as the fastest growing market worldwide, with a CAGR of 2.5% through the analysis period. Growing pharma and life science research in the region, particularly in countries such as China and India, alongside lower cost of ELISA are fueling demand for ELISA in the region. 

Major players in the market include American Laboratory Products Company (ALPCO), BD Biosciences, BioLegend Inc., Bio-Rad Laboratories Inc., Enzo Life Sciences Inc., Merck KgaA, Mercodia AB, R&D Systems Inc. and Thermo Fisher Scientific Inc., among others.

The research report titled “Research ELISA (Enzyme-Linked Immunosorbent Assay): A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for Research ELISA (Enzyme-Linked Immunosorbent Assay) in value terms for all major geographic markets such as United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), Latin America  and Rest of World. Segments analyzed include ELISA Development Sets & Antibody Pairs, and ELISA Kits.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.